Trevi Therapeutics, Inc. (TRVI)
Latest TRVI Insider Trades
About Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
- NEW HAVEN, CT
- 34
- 2019
- XNAS
https://www.trevitherapeutics.comSEC filings for TRVI on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 175,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
TRVI Insider Transactions (Form 4)
1917 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Edward T. Mathers | Grant or award | Nonstatutory Stock Option (right to buy) | 35,000 | $0.00 |
Recent TRVI Form 8-K Filings
5TRVI Insider Trading - FAQ
What is the latest insider trade for TRVI?
Trevi Therapeutics, Inc. (TRVI) had 5 insider filings in the last 90 days, with the most recent on 2026-06-04. The full record for TRVI runs to 17 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying TRVI stock?
No insider purchases of TRVI were filed in the last 90 days.
How many insiders are selling TRVI stock?
No insider sales of TRVI were filed in the last 90 days.
Where can I see TRVI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks TRVI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow TRVI insider buys?
Create a free InsiderAlpha account and press Watch on this page to add TRVI to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Edward T. Mathers view on EDGAR
- - Dominick Colangelo view on EDGAR
- - David P. Meeker view on EDGAR
- - Anne Vanlent view on EDGAR
- - Michael Thomas Heffernan view on EDGAR
- - James V. Cassella view on EDGAR
- - Christopher Galletta view on EDGAR
- - Thomas Sciascia view on EDGAR
- - Jennifer L. Good view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where TRVI's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track TRVI insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
